Heparanase‐induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice
Physiological Reports · 2024-10 · 12 (20)
DOI: 10.14814/phy2.70113 ↗At a glance
Journal article in Physiological Reports, published online on 2024-10-24. Written by Kentaro Noda and 6 co-authors. Institution: Division of Lung Transplant and Lung Failure, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Reperfusion Injury, Glycocalyx, Glucuronidase, Lung. Cited 8 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Pitt | Vascular Medicine Institute, University of Pittsburgh (VMI), Hemophilia Center of Western Pennsylvania (HCWP), Vascular Medicine Institute, University of Pittsburgh.
Abstract (original language)
The endothelial glycocalyx (eGC) is a carbohydrate‐rich layer on the vascular endothelium, and its damage can lead to endothelial and organ dysfunction. Heparanase (HPSE) degrades the eGC in response to cellular stress, but its role in organ dysfunction remains unclear. This study investigates HPSE's role in lung ischemia–reperfusion (I/R) injury. A left lung hilar occlusion model was used in B6 wildtype (WT) and HPSE genetic knockout ( −/− ) mice to induce I/R injury in vivo. The left lungs were ischemic for 1 h followed by reperfusion for 4 h prior to investigations of lung function and eGC status. Data were compared between uninjured lungs and I/R‐injured lungs in WT and HPSE −/− mice. WT lungs showed significant functional impairment after I/R injury, whereas HPSE −/− lungs did not. Inhibition or knockout of HPSE prevented eGC damage, inflammation, and cellular migration after I/R injury by reducing matrix metalloproteinase activities. HPSE −/− mice exhibited compensatory regulation of related gene expressions. HPSE facilitates eGC degradation leading to inflammation and impaired lung function after I/R injury. HPSE may be a therapeutic target to attenuate graft damage in lung transplantation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Lung Transplant and Lung Failure, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
- Section of Thoracic Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA.
ORCID profiles: Kentaro Noda, Mark E Snyder, Xi Ren, Pablo G Sanchez
Funding
- Pitt | Vascular Medicine Institute, University of Pittsburgh (VMI)
- Hemophilia Center of Western Pennsylvania (HCWP)
- Vascular Medicine Institute, University of Pittsburgh
Cite
APA
Noda, K., Atale, N., Al-Zahrani, A., Furukawa, M., Snyder, M. E., Ren, X., & Sanchez, P. G. (2024). Heparanase‐induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice. Physiological Reports, 12(20). https://doi.org/10.14814/phy2.70113
Vancouver
Noda K, Atale N, Al-Zahrani A, Furukawa M, Snyder ME, Ren X, et al. Heparanase‐induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice. Physiological Reports. 2024;12(20). doi:10.14814/phy2.70113
BibTeX
@article{Noda2024,
author = {Noda, Kentaro and Atale, Neha and Al-Zahrani, Amer and Furukawa, Masashi and Snyder, Mark E and Ren, Xi and Sanchez, Pablo G},
title = {Heparanase‐induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice},
journal = {Physiological Reports},
year = {2024},
volume = {12},
number = {20},
doi = {10.14814/phy2.70113}
}
EUVIMED